Akademik Veri Yönetim Sistemi
ACTA PHARMACEUTICA SCIENCIA, cilt.61, sa.4, ss.355-369, 2023 (Scopus)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder impacting
cognitive function and daily activities. Pharmacists’ accessibility enables them to
contribute to rational drug use, monitor interactions, and educate patients and caregivers, improving health outcomes. This study investigates pharmacists’ knowledge of AD. A descriptive study in Türkiye utilized a web-based questionnaire with
demographic questions and the Alzheimer’s Disease Knowledge Scale (ADKS). 185
participants (72.43% female, mean age 36.9±11.9) exhibited significant knowledge
of Alzheimer’s disease (mean ADKS score: 7.48±1.18). Scores varied across factors
like gender, age groups, professional experience, and geographical region. Statistically significant correlations were found between these factors and specific domains of AD knowledge. AD necessitates specialized care, and pharmacists’ services
improve health outcomes for patients and families. Cognitive pharmacy services
for complex treatment regimens benefit AD patients and their relatives. A multidisciplinary approach is crucial in effectively addressing the impact of AD and
providing optimal treatment.